Hims & Hers Stock Is Due for a Crash Diet. The Weight-Loss Drug Surge Is Fading Fast.
The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents. The knockoff surge was led by Hims & Hers Health, the telehealth firm that ...
Hims & Hers’ Weight-Loss Empire Hits a Gut-Wrenching End
Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...
Hims & Hers Has Superstar Potential, But It Will Take A Lot To Get There
Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...
Hims & Hers bought a skincare startup for $190 million 4 years ago. Today it shut it down.
Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public telehealth company.
Conway Daily Sun11d
New Yorkers say willpower is the biggest reason they can't lose weight—see what other cities think is their biggest barrier
Hers looks at how weight loss barriers differ across the U.S.
Yahoo Finance5d
Hims & Hers stock tumbles as the FDA issues a warning about 'unapproved' weight loss drugs
Hims & Hers (HIMS ... shifts in the weight-loss drug industry. Hims stock took a hit just a day after the U.S. Food and Drug Administration (FDA) updated a page on its website outlining its ...
Business Insider16d
Hims & Hers bought a skincare startup for $190 million 4 years ago. Today it shut it down.
According to a message on Apostrophe's website, all subscriptions will ... two blockbuster drugs used for weight loss. Hims & Hers has bet big on prescribing compounded versions of these drugs ...